Chemomab Therapeutics Ltd logo

Chemomab Therapeutics Ltd (CMMB) live share price

Chemomab Therapeutics Ltd share price in USD $1.82 & INR ₹154.14

$1.82

0.04

(2.25%)

View live Chemomab Therapeutics Ltd share price in Dollar and Rupees. Guide to invest in Chemomab Therapeutics Ltd from India. Also see the sentimental analysis on Indian investors investing in Chemomab Therapeutics Ltd. Get details on the Indian mutual funds that are investing in Chemomab Therapeutics Ltd. Get Analyst recommendations and forecasts along with all the Chemomab Therapeutics Ltd's financials.

Chemomab Therapeutics Ltd share price movements

  • $1.75
    $1.86

    Day's Volatility :5.91%

  • $0.42
    $2.55

    52 Weeks Volatility :83.53%

Chemomab Therapeutics Ltd Returns

PeriodChemomab Therapeutics LtdSector (Health Care)Index (Russel 2000)
3 Months
-26.02%
-6.2%
0.0%
6 Months
49.18%
2.6%
0.0%
1 Year
250.0%
11.8%
0.0%
3 Years
-76.18%
13.3%
-19.8%

Chemomab Therapeutics Ltd Key Statistics

in dollars & INR

Market Capitalization
$33.6M
Revenue TTM
$0.0
EBITDA
$-16.0M
Earnings Per Share (EPS)
$-0.94
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-93.8%

How to invest in Chemomab Therapeutics Ltd from India?

It is very easy for Indian residents to invest directly in Chemomab Therapeutics Ltd from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Chemomab Therapeutics Ltd stock in both rupees (INR) and dollars (USD). Search for Chemomab Therapeutics Ltd or CMMB on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Chemomab Therapeutics Ltd or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Chemomab Therapeutics Ltd shares which would translate to 0.465 fractional shares of Chemomab Therapeutics Ltd as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Chemomab Therapeutics Ltd

-8%

Period: Sep 2, 2024 to Dec 1, 2024. Change in 30 Days versus previous period

Search volume for Chemomab Therapeutics Ltd on INDmoney from India has reduced in the last 30 days as on Dec 2, 2024. -8% less investors are searching Chemomab Therapeutics Ltd in the last 30 days versus the previous period.

Global Institutional Holdings in Chemomab Therapeutics Ltd

    Analyst Recommendation on Chemomab Therapeutics Ltd

    Buy

      75%Buy

      25%Hold

      0%Sell

    Based on 8 Wall street analysts offering stock ratings for Chemomab Therapeutics Ltd(by analysts ranked 0 to 5 stars)

    Based on 8 analyst
    • Current
    • 1M Ago
    • 3M Ago
    Buy
    6
    6
    6
    Hold
    2
    2
    2
    Sell
    0
    0
    0

    Analyst Forecast on Chemomab Therapeutics Ltd

    What analysts predicted

    Upside of 339.56%

    Current:

    $1.82

    Target:

    $8.00

    Insights on Chemomab Therapeutics Ltd

    • Vs VRTX

      In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.4% return, outperforming this stock by 117.3%

    Chemomab Therapeutics Ltd Technicals Summary

    Sell

    Neutral

    Buy

    Chemomab Therapeutics Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

    Chemomab Therapeutics Ltd Vs Peers

    Company Name1 Month6 Month1 Year3 Years5 Years
    Chemomab Therapeutics Ltd
    26.39%
    49.18%
    250.0%
    -76.18%
    -99.57%
    Regeneron Pharmaceuticals, Inc.
    -9.49%
    -24.18%
    -8.88%
    18.12%
    102.78%
    Biontech Se
    8.64%
    15.09%
    18.5%
    -65.59%
    454.0%
    Alnylam Pharmaceuticals, Inc.
    -6.25%
    68.21%
    46.39%
    47.68%
    107.47%
    Vertex Pharmaceuticals Incorporated
    -0.99%
    -0.44%
    33.51%
    129.69%
    109.07%
    Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
    Chemomab Therapeutics Ltd
    NA
    NA
    NA
    -0.05
    -0.94
    -0.46
    NA
    1.2
    Regeneron Pharmaceuticals, Inc.
    18.66
    18.66
    1.12
    44.91
    0.17
    0.07
    NA
    272.04
    Biontech Se
    160.8
    NA
    0.04
    -3.06
    -0.02
    -0.01
    NA
    79.73
    Alnylam Pharmaceuticals, Inc.
    NA
    NA
    -0.49
    -0.19
    -15.01
    -0.03
    NA
    0.25
    Vertex Pharmaceuticals Incorporated
    32.84
    NA
    1.22
    0.54
    -0.03
    0.12
    NA
    60.65
    Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
    Chemomab Therapeutics Ltd
    Buy
    $33.6M
    -99.57%
    NA
    0.0%
    Regeneron Pharmaceuticals, Inc.
    Buy
    $83.0B
    102.78%
    18.66
    33.61%
    Biontech Se
    Buy
    $28.9B
    454.0%
    160.8
    -15.36%
    Alnylam Pharmaceuticals, Inc.
    Buy
    $32.7B
    107.47%
    NA
    -15.86%
    Vertex Pharmaceuticals Incorporated
    Buy
    $119.6B
    109.07%
    32.84
    -4.51%

    About Chemomab Therapeutics Ltd

    chemomab ltd. is a clinical-stage biotech company, focusing on discovery and development of innovative therapeutics for fibrosis-related diseases with large unmet need. chemomab is making great strides with its novel cm-101 proprietary platform, which hinders the fundamental function of the soluble chemokine ccl24 as a regulator of major inflammatory and fibrotic pathways in multiple fibrosis-related disorders. cm-101, the company’s lead clinical candidate, is a first-in-class monoclonal antibody that targets ccl24. chemomab has shown that cm-101 interferes with the underlying biology of fibrosis using a novel and differentiated mechanism of action. chemomab is actively advancing cm-101 into phase 2 studies to treat patients with liver fibrosis (primary sclerosing cholangitis and non-alcoholic steatohepatitis) and patients suffering from skin and lung fibrosis (systemic sclerosis).
    Organization
    Chemomab Therapeutics Ltd
    Employees
    0
    CEO
    Dr. Adi Mor George Ph.D.
    Industry
    Healthcare

    Important FAQs about investing in Chemomab Therapeutics Ltd from India :

    What is Chemomab Therapeutics Ltd share price today?

    Chemomab Therapeutics Ltd (CMMB) share price today is $1.82.

    Can Indians buy Chemomab Therapeutics Ltd shares?

    Yes, Indians can invest in the Chemomab Therapeutics Ltd (CMMB) from India.

    With INDmoney, you can buy Chemomab Therapeutics Ltd at 0 brokerage. The step-by-step process is as follows:

    • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
    • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
    • Once funds are transferred successfully, you can buy Chemomab Therapeutics Ltd at zero transaction cost.

    How can I buy Chemomab Therapeutics Ltd shares from India?

    It is very easy to buy Chemomab Therapeutics Ltd from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

    Can Fractional shares of Chemomab Therapeutics Ltd be purchased?

    Yes, you can buy fractional shares of Chemomab Therapeutics Ltd with INDmoney app.

    What are the documents required to start investing in Chemomab Therapeutics Ltd stocks?

    To start investing in Chemomab Therapeutics Ltd, You will need the following documents:

    • Proof of Identification (PAN, Aadhaar etc)
    • Proof of address (Aadhaar, Voter ID etc)

    These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

    What are today’s High and Low prices of Chemomab Therapeutics Ltd

    Today’s highest price of Chemomab Therapeutics Ltd (CMMB) is $1.86.

    Today’s lowest price of Chemomab Therapeutics Ltd (CMMB) is $1.75.

    What is today's market capitalisation of Chemomab Therapeutics Ltd

    Today's market capitalisation of Chemomab Therapeutics Ltd CMMB is 33.6M

    What is the 52 Week High and Low Range of Chemomab Therapeutics Ltd

    • 52 Week High

      $2.55

    • 52 Week Low

      $0.42

    How much percentage Chemomab Therapeutics Ltd is down from its 52 Week High?

    Chemomab Therapeutics Ltd (CMMB) share price is $1.82. It is down by 99% from its 52 Week High price of $2.55.

    How much percentage Chemomab Therapeutics Ltd is up from its 52 Week low?

    Chemomab Therapeutics Ltd (CMMB) share price is $1.82. It is up by 1% from its 52 Week Low price of $0.42.

    What are the historical returns of Chemomab Therapeutics Ltd?

    • 1 Month Returns

      26.39%

    • 3 Months Returns

      49.18%

    • 1 Year Returns

      250%

    • 5 Years Returns

      -99.57%

    Who is the Chief Executive Officer (CEO) of Chemomab Therapeutics Ltd

    Dr. Adi Mor George Ph.D. is the current Chief Executive Officer (CEO) of Chemomab Therapeutics Ltd.